|
Infections, immunity, and inflammation in cancer
|
ZIA CP010150-10401
|
$12,309
|
$12,309
|
A Engels, Eric
|
DCEG (NCI)
|
|
Family Studies
|
ZIA CP004410-08285
|
$964,473
|
$96,447
|
A Tucker, Margaret
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$72,809
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$2,670
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$93,793
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$268,190
|
$268,190
|
Barchi, Joseph
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$109,331
|
$27,333
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$382,659
|
$76,532
|
Bates, Susan
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$29,318
|
$29,318
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$87,953
|
$43,977
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$175,907
|
$35,181
|
Bottaro, Donald
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents
|
ZIA BC 006198
|
$701,769
|
$526,326
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$875,336
|
$43,767
|
Carrington, Mary
|
CCR (NCI)
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer and Inflammation - Genetics and Function
|
ZIA BC 005652
|
$517,266
|
$51,727
|
Dean, Michael
|
CCR (NCI)
|
|
Complex Human Diseases - From Gene to Function to Therapy
|
ZIA BC 005725
|
$517,266
|
$51,727
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$47,375
|
$23,687
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,243,310
|
$683,821
|
Edelman, Daniel
|
CCR (NCI)
|
|
Technical Development of Molecular Profiling Technologies
|
ZIC BC 011041
|
$310,828
|
$310,828
|
Edelman, Daniel
|
CCR (NCI)
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-22
|
$83,653
|
$837
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Characterization of Cancer Stem Cells
|
ZIA BC 010794
|
$730,966
|
$109,645
|
Farrar, William
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$312,228
|
$62,446
|
Feldman, Steven
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA011083-42
|
$359,154
|
$3,592
|
FISHER, RICHARD
|
UNIVERSITY OF ROCHESTER
|
|
Southwest Oncology Group
|
5U10CA014028-36
|
$221,046
|
$2,210
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$490,729
|
$196,292
|
Fojo, Antonio
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,416,561
|
$441,656
|
Fojo, Antonio
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$240,008
|
$48,002
|
Fowler, Daniel
|
CCR (NCI)
|
|
Southwest Oncology Group/ University of California,
|
5U10CA046441-22
|
$348,516
|
$3,485
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$570,017
|
$57,002
|
Garfield, Susan
|
CCR (NCI)
|
|
Research Nursing
|
ZID BC 010950
|
$3,823,571
|
$191,179
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Medical Director's Office
|
ZID BC 010951
|
$1,706,951
|
$17,070
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Serum Antibody Profiling with a Carbohydrate Microarray
|
ZIA BC 011055
|
$258,885
|
$51,777
|
Gildersleeve, Jeffrey
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$956,040
|
$47,802
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$637,360
|
$31,868
|
Gottesman, Michael
|
CCR (NCI)
|
|
Branch Clinical Research Core
|
ZID BC 010963
|
$1,239,800
|
$123,980
|
Gress, Ronald
|
CCR (NCI)
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-06
|
$215,937
|
$2,159
|
HERBST, ROY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$787,346
|
$118,102
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$1,042,212
|
$416,885
|
Hou, Steven
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,339,887
|
$133,989
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
|
ZIC BC 010630
|
$616,122
|
$123,224
|
Janik, John
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$726,889
|
$36,344
|
Khan, Javed
|
CCR (NCI)
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
ZIA BC 011002
|
$172,158
|
$17,216
|
Khan, Javed
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$731,183
|
$73,118
|
Kleiner, David
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$3,102
|
$3,102
|
Kong, Heidi
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA058882-17
|
$262,855
|
$2,629
|
LENZ, HEINZ
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$301,445
|
$60,289
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$513,824
|
$385,368
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,027,647
|
$770,735
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,027,647
|
$1,017,371
|
Linehan, W. Marston
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $15,280,944
|